Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Titan Pharmaceuticals Inc. (TTNP)
:TTNP
Holding TTNP?
Track your performance easily
TTNP Stock Chart & Stats
Day’s Range― - ―
52-Week Range$3.03 - $14.80
Previous CloseN/A
Volume3.24K
Average Volume (3M)38.05K
Market Cap
$2.88M
Enterprise ValueN/A
Total Cash (Recent Filing)$14.01M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.05
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-6.89
Shares Outstanding914,234
10 Day Avg. Volume40,917
30 Day Avg. Volume38,054
Standard Deviation0.24
R-Squared0.06
Alpha-0.05
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)2875.27
Price to Cash Flow (P/CF)-1.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Titan Pharmaceuticals News
PremiumCompany Announcements
Titan Pharmaceuticals Appoints Chay Weei Jye as CEO
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
TTNP FAQ
What was Titan Pharmaceuticals Inc.’s price range in the past 12 months?
Titan Pharmaceuticals Inc. lowest stock price was $3.03 and its highest was $14.80 in the past 12 months.
What is Titan Pharmaceuticals Inc.’s market cap?
Titan Pharmaceuticals Inc.’s market cap is $2.88M.
When is Titan Pharmaceuticals Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Titan Pharmaceuticals Inc.’s earnings last quarter?
Titan Pharmaceuticals Inc. released its earnings results on Nov 13, 2023. The company reported -$0.022 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.022.
Is Titan Pharmaceuticals Inc. overvalued?
According to Wall Street analysts Titan Pharmaceuticals Inc.’s price is currently Overvalued.
Does Titan Pharmaceuticals Inc. pay dividends?
Titan Pharmaceuticals Inc. does not currently pay dividends.
What is Titan Pharmaceuticals Inc.’s EPS estimate?
Titan Pharmaceuticals Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Titan Pharmaceuticals Inc. have?
Titan Pharmaceuticals Inc. has 914,234 shares outstanding.
What happened to Titan Pharmaceuticals Inc.’s price movement after its last earnings report?
Titan Pharmaceuticals Inc. reported an EPS of -$0.022 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 4.556%.
Which hedge fund is a major shareholder of Titan Pharmaceuticals Inc.?
Currently, no hedge funds are holding shares in TTNP
---
Company Description
Titan Pharmaceuticals Inc.
Titan Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in development of therapeutics for the treatment of medical disorders. Its products include Probuphine, Ropinirole Implant, and T3 Implant. The company was founded by Louis R. Bucalo in February 7, 1992 and is headquartered in South San Francisco, CA.
---
Technical Analysis
---